YARROW BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
YARROW BIOSCIENCE, INC. (YARW) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $3.60 million for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-06-03.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-06-03
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $1.20M.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2018 was $2.60M, a 420.00% increase from fiscal 2017.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2017 was $500.00K, a 150.00% increase from fiscal 2016.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2016 was $200.00K, a 19900.00% increase from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month as first filed |
|---|---|---|
| 2025-12-31 | $3.60M S-4/A · filed 2026-06-03 | |
| 2024-12-31 | $1.60M S-4/A · filed 2026-06-03 | |
| 2023-12-31 | $1.20M 10-K · filed 2025-03-06 | |
| 2018-12-31 | $2.60M 10-K · filed 2019-02-28 | |
| 2017-12-31 | $500.00K 10-K · filed 2019-02-28 | $539.00K 10-K · filed 2018-03-28 |
| 2016-12-31 | $200.00K 10-K · filed 2019-02-28 | $182.00K 10-K · filed 2018-03-28 |
| 2015-12-31 | $1.00K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |